SCHEMBL16628774

SCHEMBL16628774

Nc1nc(C(=O)NCCc2cccnc2)c2ccccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.58
MEN1 O00255 1/20 0.58
NPC1 O15118 1/20 0.58
KMT2A Q03164 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
ADORA2A P29274 3/20 0.57
ADORA1 P30542 3/20 0.57
NAMPT P43490 4/20 0.56
ADORA3 P0DMS8 2/20 0.54
ADORA2B P29275 1/20 0.54
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
PTAFR P25105 2/20 0.52
TBXAS1 P24557 2/20 0.52
PTGFR P43088 1/20 0.50
EPHX2 P34913 1/20 0.50
GBA1 P04062 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081056 0.89 ADORA2A (0.70) RAB9ANPC1SMN1; SMN2ADORA2AADORA1
SCHEMBL3093862 0.83 ADORA2A (0.62) RAB9ANPC1SMN1; SMN2ADORA2AADORA1
SCHEMBL3076505 0.81 ADORA2A (0.68) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3087954 0.81 ADORA2A (0.66) RAB9ANPC1SMN1; SMN2ADORA2AADORA1
SCHEMBL16628795 0.81 ADORA3 (0.66) RAB9AMEN1NPC1KMT2ASMN1; SMN2
SCHEMBL3090422 0.81 ADORA2A (0.65) RAB9ANPC1ADORA2AADORA1ADORA3
SCHEMBL16628733 0.81 ADORA2A (0.59) RAB9ANPC1SMN1; SMN2ADORA2AADORA1
SCHEMBL16628744 0.80 ADORA2A (0.71) RAB9AMEN1NPC1KMT2ASMN1; SMN2
SCHEMBL4662136 0.80 RAB9A (0.83) RAB9AMEN1NPC1KMT2ASMN1; SMN2
SCHEMBL3087918 0.79 ADORA3 (0.62) RAB9ANPC1SMN1; SMN2ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164833-B1 Quinazolinamide derivatives useful for the treatment of tumour diseases MERCK PATENT GMBH (DE) 2015-04-15 EP claimed